Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

Oak Ridge Eye Center’s Dr. Thomas Dahl will speak at 1:30 p.m. Oct. 21, 2024. He will answer other eye health-related ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

Age-related macular degeneration (AMD) is associated with a higher risk for rheumatoid arthritis (RA), according to a study ...

Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) data for EYLEA HD (aflibercept) Injection 8 mg from an ...

The quest to find a cure for the UK’s biggest cause of sight loss will be brought sharply into focus at a support group for ...

Roche (RHHBY) announced positive topline one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...

Christina Y Weng, MD, MBA sat down to discuss the Retina Ophthalmic Technology Assessment Symposium and her journal on ...

According to data presented in a late-breaking oral presentation at the American Academy of Ophthalmology 2024 Annual Meeting ...